Volume 20 Number 3
31 March 2018

Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 3, 31 March

[No authors listed]
Medulloblastoma Circulating Tumor Cells Form Leptomeningeal Metastases.
Cancer Discov. 2018 Mar 2, 2018;8(4):383. doi: 10.1158/2159-8290.CD-RW2018-035. PMID: 29500296. Comment. ˍ
Refers to: Garzia L et al., A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases. Cell. 2018 Feb 22, 2018;172(5):1050-1062.e14. doi: 10.1016/j.cell.2018.01.038. PMID: 29474906. Laboratory investigation. ˍ
Corrected online 2018 Mar 7.

Broniscer A, Jia S, Mandrell B, Hamideh D, Huang J, Onar-Thomas A, Gajjar A, Raimondi SC, Tatevossian RG, Stewart CF.
Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
Pediatr Blood Cancer. 2018 Mar 7, 2018;65(7):e27035. doi: 10.1002/pbc.27035. PMID: 29512900. Interventional study. ˍ

Yang DY, Bu XY, Zhou ZL, Yan ZY, Ma CX, Qu MQ, Zhao YW, Kong LF, Wang YW, Luo JC.
Enhanced antitumor effects of radiotherapy combined local nimustine delivery rendezvousing with oral temozolomide chemotherapy in glioblastoma patients.
J Cancer Res Ther. 2018 Mar 8, 2018;14(1):78-83. doi: 10.4103/jcrt.JCRT_844_17. PMID: 29516964. Observational study. ˍ

Matsuda M, Ishikawa E, Yamamoto T, Hatano K, Joraku A, Iizumi Y, Masuda Y, Nishiyama H, Matsumura A.
Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody.
J Neurooncol. 2018 Mar 9, 2018;138(3):581-589. doi: 10.1007/s11060-018-2825-5. PMID: 29524126. Laboratory investigation. ˍ

Fernandes Cabral DT, Zenonos GA, Nuñez M, Celtikci P, Snyderman C, Wang E, Gardner PA, Fernandez-Miranda JC.
Endoscopic Endonasal Transclival Approach for Resection of a Pontine Glioma: Surgical Planning, Surgical Anatomy, and Technique.
Oper Neurosurg (Hagerstown). 2018 Mar 12, 2018;15(5):589-599. doi: 10.1093/ons/opy005. PMID: 29538708. Case report. ˍ

Smit M, Van Stralen HE, Van den Munckhof B, Snijders TJ, Dijkerman HC.
The man who lost his body: Suboptimal multisensory integration yields body awareness problems after a right temporoparietal brain tumour.
J Neuropsychol. 2018 Mar 12, 2019;13(3):603-612. doi: 10.1111/jnp.12153. PMID: 29532598. Case report. ˍ

Rammo R, Asmaro K, Schultz L, Scarpace L, Siddiqui S, Walbert T, Kalkanis S, Lee I.
The safety of magnetic resonance imaging-guided laser interstitial thermal therapy for cerebral radiation necrosis.
J Neurooncol. 2018 Mar 13, 2018;138(3):609-61. doi: 10.1007/s11060-018-2828-2. PMID: 29536345. Observational study. ˍ

Bette S, Barz M, Huber T, Straube C, Schmidt-Graf F, Combs SE, Delbridge C, Gerhardt J, Zimmer C, Meyer B, Kirschke JS, Boeckh-Behrens T, Wiestler B, Gempt J.
Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume.
Sci Rep. 2018 Mar 14, 2018;8(1):4561. doi: 10.1038/s41598-018-22697-9. PMID: 29540809. Observational study. ˍ

Guan Y, Chen J, Zhan Y, Lu H.
Effects of dexamethasone on C6 cell proliferation, migration and invasion through the upregulation of AQP1.
Oncol Lett. 2018 Mar 15, 2018;15(5):7595-7602. doi: 10.3892/ol.2018.8269. PMID: 29740485. Laboratory investigation. ˍ

Mata-Mbemba D, Zapotocky M, Laughlin S, Taylor MD, Ramaswamy V, Raybaud C.
MRI Characteristics of Primary Tumors and Metastatic Lesions in Molecular Subgroups of Pediatric Medulloblastoma: A Single-Center Study.
AJNR Am J Neuroradiol. 2018 Mar 15, 2018;39(5):949-955. doi: 10.3174/ajnr.A5578. PMID: 29545246. Observational study. ˍ

Weinberg BD, Boreta L, Braunstein S, Cha S.
Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.
J Neurooncol. 2018 Mar 15, 2018;138(3):549-556. doi: 10.1007/s11060-018-2822-8. PMID: 29546530. Observational study. ˍ

Kuga D, Hata N, Akagi Y, Amemiya T, Sangatsuda Y, Hatae R, Yoshimoto K, Mizoguchi M, Iihara K.
The Effectiveness of Salvage Treatments for Recurrent Lesions of Oligodendrogliomas Previously Treated with Upfront Chemotherapy.
World Neurosurg. 2018 Mar 16, 2018;114:e735-e742. doi: 10.1016/j.wneu.2018.03.069. PMID: 29551724. Observational study. ˍ

Wang C, Sun W, Kirkpatrick J, Chang Z, Yin FF.
Assessment of concurrent stereotactic radiosurgery and bevacizumab treatment of recurrent malignant gliomas using multi-modality MRI imaging and radiomics analysis.
J Radiosurg SBRT. 2018 [Mar 16], 2018;5(3):171-181
. PMID: 29988289. Observational study. ˍ

Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG).
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
J Neurooncol. 2018 Mar 20, 2018;138(3):627-636. doi: 10.1007/s11060-018-2831-7. PMID: 29557060. Interventional study. ˍ

Liu Y, Feng F, Ji P, Liu B, Ge S, Yang C, Lou M, Liu J, Li B, Gao G, Qu Y, Wang L.
Improvement of health related quality of life in patients with recurrent glioma treated with bevacizumab plus daily temozolomide as the salvage therapy.
Clin Neurol Neurosurg. 2018 Mar 27;169:64-70. doi: 10.1016/j.clineuro.2018.03.026. PMID: 29631109. Observational study. ˍ

Nassiri F, Aldape K, Zadeh G.
The multiforme of glioblastoma.
Neuro Oncol. 2018 Mar 27, 2018;20(4):437-438. doi: 10.1093/neuonc/noy025. PMID: 29596671. Comment. ˍ
Refers to: Mahlokozera T,et al.,Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma. Neuro Oncol. 2017 Dec 13, 2018;20(4):472-483. doi: 10.1093/neuonc/nox232. PMID: 29244145. Laboratory investigation. ˍ

Ostrom QT, Rubin JB, Lathia JD, Berens ME, Barnholtz-Sloan JS.
Females have the survival advantage in glioblastoma.
Neuro Oncol. 2018 Feb 21, 2018;20(4):576-577. doi: 10.1093/neuonc/noy002. PMID: 29474647. Letter to the Editor / Observational study. ˍ